Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

isradipine

ISRADIPINE

isradipine (ISRADIPINE) is a voltage-gated l-type calcium channel blocker. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 11
Pipeline programs 2
News articles 0
Drug details — isradipine
US status
approved
Class
—
Route
ORAL
Patents
11
Programs
2
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

isradipine (ISRADIPINE) is a voltage-gated l-type calcium channel blocker. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN isradipine
Brand ISRADIPINE
Mechanism Voltage-gated L-type calcium channel blocker
Target Voltage-gated L-type calcium channel
Route ORAL
Formulation CAPSULE
Originator ELITE PHARMACEUTICALS INC /NV/

Mechanism of action

Voltage-gated L-type calcium channel blocker

Primary target: Voltage-gated L-type calcium channel

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. Isradipine Phase 2 · BRIGHT MINDS BIOSCIENCES · Opioid Dependence
  2. Isradipine Phase 1 · BRIGHT MINDS BIOSCIENCES · Nicotine Dependence

Related & competitor drugs

Browse all drugs
  1. amlodipine benzoate Voltage-gated L-type calcium channel blocker
  2. amlodipine besylate Voltage-gated L-type calcium channel blocker
  3. diltiazem hydrochloride Voltage-gated L-type calcium channel blocker
  4. nicardipine hydrochloride Voltage-gated L-type calcium channel blocker
  5. nifedipine Voltage-gated L-type calcium channel blocker
  6. verapamil hydrochloride Voltage-gated L-type calcium channel blocker

Related patents

Browse patents ELITE PHARMACEUTICALS INC /NV/ patent hub

  1. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12295394

    Water-soluble additive composition

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11389444

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10213388

    Abuse resistant oral dosage forms

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9125822

    Particle for medical use and process for producing the same

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9056054

    Abuse resistant oral dosage forms

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8529257

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7018465

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is isradipine?

isradipine (ISRADIPINE) is a voltage-gated l-type calcium channel blocker. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for isradipine?

ISRADIPINE is a marketed brand name for isradipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of isradipine?

isradipine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.